Today: 2 March 2026

Mateusz Kaczmarek

A technology and finance expert writing for TS2.tech. He analyzes developments in satellites, telecommunications, and artificial intelligence, with a focus on their impact on global markets. Author of industry reports and market commentary, often cited in tech and business media. Passionate about innovation and the digital economy.

Vita Coco (COCO) Soars on Tariff Relief and BofA Upgrade as Stock Hits New High – 17 November 2025

Vita Coco (COCO) Soars on Tariff Relief and BofA Upgrade as Stock Hits New High – 17 November 2025

Vita Coco shares hit a record $48.86 on Monday after the White House exempted coconut water from new U.S. reciprocal tariffs, slashing the company’s average tariff rate from 23% to 6%. Bank of America upgraded the stock to Buy and raised its price target to $54. Q3 net sales rose 37% to $182 million. As of late trading, COCO shares were around $47–48.
17 November 2025
PowerBank (SUUN) Returns to Profitability: Q1 2026 Earnings, AI Deal and Stock Reaction on 17 November 2025

PowerBank (SUUN) Returns to Profitability: Q1 2026 Earnings, AI Deal and Stock Reaction on 17 November 2025

PowerBank Corporation reported a net profit of CAD 1.01 million for Q1 fiscal 2026, reversing a CAD 26.49 million loss a year earlier. Revenue rose to CAD 19.15 million, driven by the operational launch of the Geddes solar project in New York and new development fee income. Gross profit more than doubled to CAD 8.54 million. Earnings per share swung to CAD 0.03 from a loss of CAD 0.87.
Albemarle (ALB) Soars as Lithium Prices Spike and Argus Lifts Target to $140 – What Investors Need to Know Today (17 November 2025)

Albemarle (ALB) Soars as Lithium Prices Spike and Argus Lifts Target to $140 – What Investors Need to Know Today (17 November 2025)

Albemarle shares surged 8–9% on November 17, 2025, trading above $120 and hitting a 52-week high as lithium prices in China jumped 9% to a one-year peak. Argus Research raised its price target to $140, citing an earnings recovery and strong balance sheet. Empower Advisory Group increased its stake by 11.4%. Albemarle beat Q3 revenue and EPS expectations but remains loss-making.
17 November 2025
Canadian Solar (CSIQ) Stock Soars on Storage Deals, Roth Price Target Hike & Insider Sales – November 17, 2025

Canadian Solar (CSIQ) Stock Soars on Storage Deals, Roth Price Target Hike & Insider Sales – November 17, 2025

Canadian Solar shares surged over 60% in November, hitting a 12-month high of $34.59 after Q3 earnings beat expectations. Roth Capital raised its price target to $30, but the average Wall Street target remains below the current $29–30 level. New deals in Canada and Germany and insider sales filings drew attention on November 17. The company reported Q3 revenue of about $1.5 billion and an adjusted EPS loss of $0.58.
Clearwater Analytics (CWAN) Soars on Warburg Pincus & Permira Buyout Buzz — Key Updates for November 17, 2025

Clearwater Analytics (CWAN) Soars on Warburg Pincus & Permira Buyout Buzz — Key Updates for November 17, 2025

Clearwater Analytics shares surged as much as 14% in pre-market trading Monday after reports that Warburg Pincus and Permira are in talks to acquire the company. The stock traded near $21.89 before the open, later settling up about 3.9% by late morning. No formal agreement has been announced. Clearwater, Warburg, and Permira declined to comment.
17 November 2025
E.W. Scripps (SSP) Soars as Sinclair Builds 8.2% Stake and Pushes for Takeover on November 17, 2025

E.W. Scripps (SSP) Soars as Sinclair Builds 8.2% Stake and Pushes for Takeover on November 17, 2025

Sinclair Inc. revealed an 8.2% stake in The E.W. Scripps Company on Nov. 17, 2025, and confirmed ongoing merger talks, pushing SSP shares up over 20%. Scripps’ board said it will protect shareholders and stick to its strategic plan. Sinclair claims the deal would bring $300 million in annual cost synergies without external financing. The proposed merger would combine more than 230 local TV stations.
Medical Properties Trust (MPW) Hikes Dividend 12% and Extends Buyback Push: What Investors Need to Know Today (17 November 2025)

Medical Properties Trust (MPW) Hikes Dividend 12% and Extends Buyback Push: What Investors Need to Know Today (17 November 2025)

Medical Properties Trust raised its quarterly dividend to $0.09 per share, up 12% from $0.08, payable January 8, 2026 to shareholders of record December 11. The announcement follows a $150 million stock buyback plan and recent Q3 results showing a net loss but higher revenue. MPW shares traded near $5.18, up 4.5% on the day, with a market cap around $3 billion.
17 November 2025
Repare Therapeutics (RPTX) Soars on XenoTherapeutics Takeover Deal: Cash + CVR Offer, Analyst Downgrade and What to Watch on 17 November 2025

Repare Therapeutics (RPTX) Soars on XenoTherapeutics Takeover Deal: Cash + CVR Offer, Analyst Downgrade and What to Watch on 17 November 2025

Repare Therapeutics shares jumped nearly 30% and traded around $2 after last week’s $78 million takeover deal with XenoTherapeutics. The offer includes about $1.82 per share in cash plus a non-transferable contingent value right tied to future asset sales and milestones. The transaction is expected to close in Q1 2026, pending shareholder and court approval in Québec.
Elbit Systems (ESLT) Jumps on $2.3 Billion Contract Win as Q3 Earnings Loom – 17 November 2025 Update

Elbit Systems (ESLT) Jumps on $2.3 Billion Contract Win as Q3 Earnings Loom – 17 November 2025 Update

Elbit Systems announced a $2.3 billion international defense contract to be delivered over eight years, with the customer and systems undisclosed. The news sent ESLT shares sharply higher on both the Nasdaq and TASE. The deal was confirmed in a press release and SEC filing one day before Elbit’s Q3 2025 earnings report.
Sociedad Química y Minera (SQM) Soars as Lithium Rebounds and Codelco JV Gets Final Green Light

Sociedad Química y Minera (SQM) Soars as Lithium Rebounds and Codelco JV Gets Final Green Light

SQM shares surged about 12% Monday in New York, hitting a 52-week high near $61 after China approved its lithium joint venture with Codelco. Major funds including Itaú Unibanco and KBC Group disclosed new or larger stakes. Lithium prices rose on signs of stronger Chinese demand. Investors await SQM’s Q3 2025 earnings report due Tuesday.
PACS Group (PACS) Stock Soars as Company Pledges to Clear SEC Filing Backlog by November 19, 2025

PACS Group (PACS) Stock Soars as Company Pledges to Clear SEC Filing Backlog by November 19, 2025

PACS Group shares surged nearly 50% to $15.90 Monday after the company said it will file all overdue SEC reports and release Q3 2025 earnings on November 19. The filings aim to resolve delisting and default risks tied to a months-long reporting backlog. PACS confirmed a $61–65 million overstatement in 2024 Medicare Part B revenue, citing an ongoing audit probe. Trading volume topped 4.3 million shares by late morning.
17 November 2025
ZIM Integrated Shipping (NYSE: ZIM) Jumps Toward $17 as Bulltick Boosts Stake Ahead of Q3 Earnings – November 17, 2025

ZIM Integrated Shipping (NYSE: ZIM) Jumps Toward $17 as Bulltick Boosts Stake Ahead of Q3 Earnings – November 17, 2025

ZIM shares jumped about 6% to $17 late morning Monday as traders positioned ahead of Thursday’s Q3 earnings report. Bulltick Wealth Management increased its stake by 33% to 88,000 shares. Options markets priced in an 11–12% move post-earnings, signaling volatility. Today is also the record date for ZIM’s December 19 shareholder meeting in Haifa.
Pfizer (PFE) Stock Today, November 17, 2025: Migraine Drug Launch in India, Metsera Deal Closes and New RSV Vaccine Data

Pfizer (PFE) Stock Today, November 17, 2025: Migraine Drug Launch in India, Metsera Deal Closes and New RSV Vaccine Data

Pfizer launched Rimegepant ODT, a migraine tablet, in India, targeting a $200 million market. Shares traded near $25.28, down 55% from late 2022, with a dividend yield around 7%. Analysts maintain a “Hold” rating and see limited short-term movement. The new product addresses migraine in adults unresponsive to standard treatments.
GameStop Stock (GME) on November 17, 2025: Retail Buzz, ‘Trade Anything Day’ Hype and New Short‑Squeeze Speculation

GameStop Stock (GME) on November 17, 2025: Retail Buzz, ‘Trade Anything Day’ Hype and New Short‑Squeeze Speculation

GameStop shares traded around $20.70 late Monday morning, up slightly after hitting a new 52-week low of $18.89 last week. The stock remains down 34% year-to-date despite recent profitable quarters and a viral “Trade Anything Day” promotion. Short interest is near a 12-month high, fueling debate among retail traders over valuation and short-squeeze potential.
17 November 2025
Social Security COLA 2026 and the $200 Boost Bill: How Much Your Check Could Really Rise (Update for November 17, 2025)

Social Security COLA 2026 and the $200 Boost Bill: How Much Your Check Could Really Rise (Update for November 17, 2025)

Social Security and SSI benefits will rise 2.8% in 2026, increasing the average retired worker’s monthly check by about $56. The taxable wage cap moves to $184,500, and the maximum benefit at full retirement age reaches $4,152 per month. Medicare Part B premiums will rise to $202.90. A Senate bill proposing a $200 monthly boost for six months in 2026 remains at the introduction stage.
17 November 2025
Rivian Stock (RIVN) Today: Price Targets Raised, Battery Bug Emerges and Big Holders Trim Stakes – November 17, 2025

Rivian Stock (RIVN) Today: Price Targets Raised, Battery Bug Emerges and Big Holders Trim Stakes – November 17, 2025

Rivian shares traded near $15.06 early afternoon November 17, down 0.3% after a surge of over 30% post-Q3 earnings. The company reported its first positive gross profit, while Stifel and Tigress Financial raised price targets. Headlines flagged a battery calibration bug in R1 models, and filings showed major investors and CEO RJ Scaringe selling shares. Volume topped 14 million.
Tesla (TSLA) News Today: China Supply Chain Shake-Up, Thiel Trims Stake, AI5 Delay and Divided Wall Street – 17 November 2025

Tesla (TSLA) News Today: China Supply Chain Shake-Up, Thiel Trims Stake, AI5 Delay and Divided Wall Street – 17 November 2025

Tesla shares rose about 2.5% to $414.46 on November 17 after Elon Musk ordered U.S. suppliers to phase out China-made parts within two years. Peter Thiel cut his Tesla stake by over 75% in Q3. Musk said the next-gen AI5 chip is delayed until mid-2027. Wall Street remains split on robotaxi prospects, with price targets ranging from $131 to $509.
1 21 22 23 24 25 140
Go toTop